MUMBAI, Nov 4 (Reuters) - Surya Pharmaceutical said on Thursday its board has approved sub-division of equity shares in a ratio of 10-for-1. (Reporting by Kaustubh Kulkarni; Editing by Sunil Nair) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results